CSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement

• Post author:GHIAA Admin
• Post published:May 24, 2022
• Post category:

Continue ReadingCSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement

BMGF – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement

• Post author:GHIAA Admin
• Post published:April 26, 2022
• Post category:

Continue ReadingBMGF – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement

BMGF – Arsanis RSV Monoclonal Antibodies Funding Agreement

• Post author:GHIAA Admin
• Post published:April 25, 2022
• Post category:

Continue ReadingBMGF – Arsanis RSV Monoclonal Antibodies Funding Agreement

Fiocruz – AstraZeneca, COVID-19 Technological Order Agreement

• Post author:GHIAA Admin
• Post published:April 18, 2022
• Post category:

Continue ReadingFiocruz – AstraZeneca, COVID-19 Technological Order Agreement

Cellscript – BioNTech mRNA Technology Patent Sublicense

• Post author:GHIAA Admin
• Post published:March 17, 2022
• Post category:

Continue ReadingCellscript – BioNTech mRNA Technology Patent Sublicense

Biological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement

• Post author:GHIAA Admin
• Post published:March 4, 2022
• Post category:

Continue ReadingBiological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement

Gavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement

• Post author:GHIAA Admin
• Post published:February 2, 2022
• Post category:

Continue ReadingGavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement

CEPI – Dynavax, COVID-19 Material Reservation Agreement

• Post author:GHIAA Admin
• Post published:January 31, 2022
• Post category:

Continue ReadingCEPI – Dynavax, COVID-19 Material Reservation Agreement

AUTM Model Inter-Institutional Research Collaboration Agreement

• Post author:GHIAA Admin
• Post published:January 18, 2022
• Post category:

Continue ReadingAUTM Model Inter-Institutional Research Collaboration Agreement